Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-062935
Filing Date
2025-05-02
Accepted
2025-05-02 17:18:49
Documents
1
Period of Report
2025-05-01

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3848
  Complete submission text file 0000950170-25-062935.txt   5329
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Issuer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O NEUROCRINE BIOSCIENCES, INC. 12790 EL CAMINO REAL SAN DIEGO CA 92130
Business Address
BENEVICH ERIC (Reporting) CIK: 0001643653 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37378 | Film No.: 25910022